WG
DXCM icon

Winton Group’s DexCom DXCM Stock Holding History

Winton Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.19M Buy
136,493
+94,631
+226% +$6.3M 0.3% 83
2026
Q1 		$2.63M Buy
+41,862
New +$2.92M 0.09% 284
2025
Q4 		– Sell
-27,101
Closed -$1.82M – 968
2025
Q3 		$1.82M Sell
27,101
-42,855
-61% -$3.39M 0.07% 281
2025
Q2 		$6.11M Buy
69,956
+28,474
+69% +$2.23M 0.31% 61
2025
Q1 		$2.83M Sell
41,482
-429
-1% -$35K 0.17% 142
2024
Q4 		$3.26M Buy
+41,911
New +$3.1M 0.22% 121
2024
Q1 		– Sell
-5,707
Closed -$708K – 674
2023
Q4 		$708K Sell
5,707
-13,093
-70% -$1.34M 0.05% 211
2023
Q3 		$1.75M Sell
18,800
-18,211
-49% -$2.05M 0.14% 113
2023
Q2 		$4.76M Buy
37,011
+14,486
+64% +$1.75M 0.4% 48
2023
Q1 		$2.62M Buy
22,525
+18,264
+429% +$2.04M 0.16% 150
2022
Q4 		$483K Sell
4,261
-91,004
-96% -$9.99M 0.03% 641
2022
Q3 		$7.67M Sell
95,265
-54,013
-36% -$4.57M 0.5% 24
2022
Q2 		$11.1M Buy
149,278
+88,946
+147% +$8.12M 0.59% 21
2022
Q1 		$7.72M Buy
60,332
+41,604
+222% +$4.55M 0.4% 38
2021
Q4 		$2.51M Buy
18,728
+4,752
+34% +$683K 0.15% 154
2021
Q3 		$1.91M Buy
13,976
+11,136
+392% +$1.4M 0.11% 200
2021
Q2 		$303K Buy
+2,840
New +$273K 0.02% 1175
2021
Q1 		– Sell
-9,236
Closed -$854K – 1388
2020
Q4 		$854K Sell
9,236
-36,020
-80% -$3.22M 0.06% 491
2020
Q3 		$4.66M Sell
45,256
-552
-1% -$57.7K 0.15% 142
2020
Q2 		$4.64M Buy
45,808
+1,888
+4% +$169K 0.12% 246
2020
Q1 		$2.96M Buy
+43,920
New +$2.73M 0.08% 437
2019
Q3 		– Sell
-9,344
Closed -$350K – 1571
2019
Q2 		$350K Sell
9,344
-8,660
-48% -$272K 0.01% 825
2019
Q1 		$536K Buy
18,004
+2,016
+13% +$70.8K 0.01% 545
2018
Q4 		$479K Buy
+15,988
New +$507K 0.01% 502

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Winton Group's DXCM Position: Q2 2026 in Review

Winton Group increased its DexCom (DXCM) stake by 226% in Q2 2026, buying an estimated $6.3M and bringing the position to 136,493 shares worth $9.19M. The position accounts for 0.3% of the portfolio, ranked #83.

Winton Group first reported a position in DXCM in Q4 2018 and has held it in 24 quarters since. The position peaked at $11.1M in Q2 2022. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Winton Group held 136,493 shares of DexCom worth $9.19M as of Q2 2026.
  • Winton Group bought 94,631 DexCom shares in Q2 2026, an estimated $6.3M.
  • DexCom made up 0.3% of Winton Group's portfolio in Q2 2026, its #83 holding.
  • Winton Group first reported a position in DexCom in Q4 2018 and has held it in 24 quarters since.
  • Winton Group's DexCom position peaked at $11.1M in Q2 2022.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.